Key Areas of Expertise:
Cancer clinical trials
Lung cancer and sarcomas
Early diagnoses of lung cancer
Professor Woll is Professor of Medical Oncology at the University of Sheffield and chair of the NCRI Sarcoma Clinical Studies Group.
Professor Woll graduated from the University of Newcastle upon Tyne and trained in Medical Oncology in London and Manchester. She was a Senior Lecturer in the University of Nottingham before being appointed to a chair in Sheffield.
Professor Woll’s main clinical and research interests are in lung cancer and sarcomas. She has extensive experience of clinical trials testing new treatments for these tumour types, and is a member of national and international collaborative groups, including NCRI and EORTC clinical trials groups.
Her laboratory research is centred on lung cancer biology. She is particularly interested in growth regulation and the role of neuropeptide growth factors in lung cancer. Recent work has focused on plasma DNA in the early diagnosis of lung cancer. Her research objective is to develop and evaluate novel approaches to the diagnosis and treatment of lung cancer and sarcomas.
She chairs the Sheffield Experimental Cancer Medicine Centre. This is supported by grant funding from Cancer Research UK and the Department of Health of £700k over 5 years. This funding has just been renewed and will be £1million over the next 5 years.
Professor Woll is also chief investigator for a number of national cancer clinical trials.
Professor Penella Woll BMedSci, MB BS, PhD, FRCP Department of Oncology Academic Unit of Clinical Oncology Weston Park Hospital Whitham Road, Sheffield S10 2SJ
Tel: +44 (0)114 226 5206
Fax: +44 (0)114 226 5364
For further information please visit: Clinical Oncology